UNIQO 160 Launch
The UNIQO 160 Marketing Playbook outlines the strategic approach used to launch EUROIMMUN US’s innovative ANA IFA automation system. This comprehensive guide details key messaging, audience segmentation, marketing campaigns, and sales enablement strategies to maximize product visibility and adoption.
Key Takeaways
- Strong Positioning & Differentiation – The UNIQO 160 stands out with its precision automation and seamless workflow integration, competing directly with Aesku’s Helios, Zeus Scientific’s dIfine 30, and Werfen’s Quantalyzer 3000.
- Multi-Channel Marketing Strategy – A mix of digital marketing, email campaigns, social media, and print advertising targeted clinical and hospital labs, driving awareness and engagement.
- Effective Tradeshow & Event Presence – Live product demos, interactive booth experiences, and lead capture strategies at major industry events, including ADLM and AMLI, reinforced product credibility.
- Data-Driven Optimization – Ongoing tracking of KPIs such as CTR, engagement, MQLs, and opportunities informed continuous improvements in messaging and outreach.
- Sustained Customer Engagement – Post-launch support included training, exclusive webinars, and quarterly updates to ensure long-term customer success and satisfaction.
By combining these elements, the UNIQO 160 launch successfully positioned the product as a market leader in autoimmune diagnostics while ensuring sustained adoption and customer retention.
Download the complete playbook below:
Let’s Work Together
I would love to discuss your projects and opportunities. I’m happy to answer questions and welcome suggestions.
Please allow up to a 24 hour response time or visit my Contact page for additional ways to connect.